癌におけるデュシェンヌ筋縮遺伝子の関与に関する統一モデル:文脈依存の腫瘍抑制と腫瘍性
Lee Machado1, Leanne Jones1,2, Sonika Divakar1
1Centre for Physical Activity and Life Sciences, University of Northampton, UK.
FEBS open bio
|August 20, 2025
まとめ
デュチェンヌ筋縮遺伝子 (DMD) は,攻撃的ながんでは腫瘍抑制剤として,攻撃性の低いがんでは腫瘍遺伝子として作用する. この文脈に依存する機能は,様々な腫瘍の患者生存結果に影響します.
科学分野:
- 腫瘍学
- 遺伝学
- 分子生物学
背景:
- デュシェンヌ筋縮遺伝子 (DMD) は癌発症に関与しているが,その正確な役割は不明である.
- DMDががん生存に及ぼす影響に関する既存の証拠は矛盾しており,さらなる調査が必要である.
研究 の 目的:
- 33種類の異なる癌の生存結果に対するDMD遺伝子発現の世界的な影響を包括的に分析する.
- 腫瘍形成における DMD の文脈依存的役割を明らかにし,腫瘍抑制機能と腫瘍発生機能を区別する.
主な方法:
- ガンゲノムアトラス (TCGA) の大量RNAシーケンシングデータをグローバル分析に利用した.
- 生き残りの関連性を評価するために,カプラン・マイヤー分析とコックスの比例的な危険モデルを使用した.
- 経路分析と階層的なクラスタリングを行い,基礎となるメカニズムを探求した.
主要な成果:
- 9つのがんの生存率と有意に相関するDMD発現 (Bonferroni修正,α=0. 0015).
- 高いDMD発現は,いくつかのがんの生存率の改善と,他のがんのアウトカム悪化と関連していました.
- デュシェンヌ筋縮遺伝子 (DMD) のトランスクリプトDp71abは,DMDの全体的な傾向を反映し,生存の相反する異なる腫瘍群を強調した.
結論:
- DMDはすべてのがんにおいて腫瘍抑制剤として均一に機能しません.
- 文脈に依存する二重モデルが提案されている:高濃度DMDは,攻撃的ながんでは腫瘍抑制であり,攻撃性の低い腫瘍では腫瘍発生性である.
- DMDの異なった効果は,シグナル伝達と粘着に関与する特定のディストロフィン関連タンパク質複合体 (DAPC) の構成要素と関連している可能性があります.
関連する概念動画
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mouse Models of Cancer Study
5.7K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.7K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Cancer-Critical Genes I: Proto-oncogenes
9.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K


